No clear relationship between the levels of IGF-1 or GH and tumor development could be demonstrated, but certain risk factors, such as diabetes mellitus (DM) and obesity, were more frequent in patients with tumors. This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.